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0929-6441/ª 2015, Elsevier Taiwan LLA 45-year-old female presented with abdominal pain for 3 days without trauma history. The
pain was located over the epigastric area with radiation to the back. A pancreatic pseudocyst
was impressed initially according to clinical symptoms, laboratory data, and image studies.
However, rapid progression of the lesions was noted later after discharge. Following image
studies showed circumscribed tumors in the head, body, and tail regions of the pancreas. Sur-
gery with the Whipple operation was performed during the second admission. The post oper-
ation course was uneventful. Pathologic results showed sarcoma of the pancreas. Primary
pancreatic sarcomas are extremely rare lesions accounting for < 0.1% of all pancreatic malig-
nancies. Pancreatic sarcomas tend to be aggressive and have a poor prognosis. In addition, <
5% of pancreatic tumors are cystic. The rarest cystic neoplasm is also the primary pancreatic
sarcoma, with only a few cases having been documented. However, it should be considered in
the differential diagnosis of pancreatic cystic lesions.
ª 2015, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
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Sarcomas represent a relatively rare malignant entity. Pri-
mary sarcomas of the pancreas are even rarer [1]. They
comprise < 0.1% of malignant pancreatic neoplasms, with
only a few cases previously documented in English litera-
ture [2]. Fewer than 5% of pancreatic tumors are cystic;of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
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tadenocarcinoma are the most common. The rarest cystic
neoplasm is the primary pancreatic sarcoma [3]. These tend
to be more aggressive and have a poor prognosis. We pre-
sent a patient with such a rare condition with pancreatic
sarcoma initially mimicking a pseudocyst.Case report
A 45-year-old female suffered from epigastric pain with
radiation to the back for several days. When she came to
our outpatient department for help, elevated amylase and
lipase levels were noted (476 U/L and 1239 U/L, respec-
tively). She was then admitted to a ward in Cheng-Ching
General Hospital, Taichung, Taiwan for further evaluation
and management under the impression of acute
pancreatitis.
After admission, an abdominal sonogram revealed:
moderate fatty liver, a cystic lesion 2 cm in the pancreatic
head, and another lesion w2.2 cm in the body of the
pancreas (see Fig. 1). Differential diagnosis included:
pseudocyst, cystic tumor or hypoechoic tumor of pancreas.
Computed tomography (CT) of the abdomen was done and
it showed: two cystic lesions and two suspected pseudo-
cysts in the pancreatic head and body. Tumor markers were
as following: Carcino Embryonic Antigen (CEA) 0.77 ng/mL
(< 5.0) and CA19-9 17.65 U/mL (< 37). After medical
treatment, the abdominal pain improved gradually. She was
discharged 5 days later. After discharge, she was followed
regularly at our outpatient department. Unfortunately, an
abdominal sonogram 2 months later showed increased sizes
of previous pancreatic lesions. Abdominal CT followed and
the results showed: four circumscribed tumors with irreg-
ular wall thickening 3.4 cm in the head, 3.2 cm and 3 cm in
the body, and 1.2 cm in the tail region of pancreas. The
patient was then admitted again for further evaluation and
management.
The patient denied a history of systemic disease or
major operations. She did not have a habit of cigarette
smoking or alcohol drinking. No previous family history of
malignancy was noted. After admission, the patient
appeared ill looking. She was conscious, lucid, andFig. 1 Abdominal ultrasonogram during the first admission.
The sonogram shows a cystic lesion 2 cm in the body of the
pancreas.cooperative. Vital signs were as follows: blood pressure
128/76 mmHg, pulse rate 88/minute, respiratory rate 18/
minute, and temperature 36.2C. Her sclera was not icteric
and the conjunctiva was not pale. Chest examination
showed clear breathing sounds over both lung fields.
Observation of the heart showed a regular heartbeat
without murmur.
Distension of the abdomen was present and mild
abdominal tenderness over the epigastric area was noted.
Laboratory data showed that the white blood cell count
was 7180 per microliter without left shifting of segment
70%, hematocrit 38.9% (34e44%), hemoglobin 13.2 g/dL
(12e16 g/dL), sodium 138 mmol/L (135e148 mmol/L), po-
tassium 3.6 mmol/L (3.5e5.0 mmol/L), blood urea nitrogen
8 mg/dL (7e20 mg/dL), creatinine 0.8 mg/dL (0.5e1.5 mg/
dL), Aspartate Aminotransferase (AST) 19 U/L (5e40 U/L),
Alanine Aminotransferase (ALT) 28 U/L (3e35 U/L), alkaline
phosphatase 124 U/L (35e104 U/L), and total bilirubin
0.3 mg/dL (0.2e1.2 mg/dL). Tumor marker levels examined
after admission including alpha-fetoprotein (AFP) 3.75 ng/
mL (< 8.78), CEA 0.69 ng/mL (< 5.0), and CA19-9 9.32 U/
mL (< 37) were within normal limits. The chest roentgen-
ogram showed normal lung fields. The electrocardiogram
showed normal sinus rhythm. On the 2nd day of admission,
an operation was performed after discussion with the pa-
tient and her family. The Whipple operation was performed
smoothly. Partial pancreatectomy, partial gastrectomy, and
splenectomy were done (see Fig. 2).
The operative findings showed many endurated mass le-
sions locating over the pancreatic head with extension to
neck, and body. The pathologic report showed sarcoma
involved all of the pancreatic lesions and pancreatitis of the
pancreas. The microscopic finding was: French Federation
of Cancer Centers Sarcoma Group (FNCLCC) Grade II sar-
coma composed of hyperchromatic spindle cell with mitosis
(10-19/10HPF), pancreatitis with lymphocytic infiltration,
focal fibrosis, and fat necrosis. Immunohistochemical stain:
CD117 (), smooth muscle actin (þ), Cytokeratin (CK) (),
S100 (), desmin (), and vimentin (þ). The post operation
course was uneventful and she was discharged 15 days after
the operation. Her condition remains stable after 12 months
of follow up from the time she was discharged (see Fig. 3).Fig. 2 Abdominal sonogram after the first admission. The
sonogram shows increased sizes of cystic lesions with irregular
wall thickening of the pancreas.
Fig. 3 Computed tomography showing: (A) a cystic lesion
2 cm in the distal body of the pancreas; and (B) pancreatic
tumors with irregular wall thickening and necrosis, 3.4 cm in
the head, 3.2 cm and 3.0 cm in the body, and 1.2 cm in the tail
region.
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Sarcomas represent a relatively rare malignant entity. Pri-
mary sarcomas of the pancreas are even rarer. Amongst
pancreatic sarcomas, leiomyosarcomas tend to occur rela-
tively frequently [1]. Other sarcomas of the pancreas re-
ported include: fibrosarcoma, carcinosarcoma,
rhabdomyosarcoma, liposarcoma, hemangioendothelioma,
malignant neurilemmoma, malignant hemangiopericytoma,
and malignant fibrous histiocytoma [3]. Yet, they comprise
only 0.1% of malignant pancreatic neoplasms [2]. Pancre-
atic sarcomas occur frequently in younger individuals. The
pancreatic caput is most commonly involved followed by
the tail and the body [1]. Patients present clinically with
epigastric abdominal pain, nausea, and vomiting. Some may
have body weight loss and the presence of an abdominal
mass. In the present case, the patient had only the same
symptoms as pancreatitis but she did not have significant
weight loss.
The diagnosis of pancreatic cancer and pancreatitis,
especially chronic pancreatitis, is notoriously problematic,
in that both diseases may have unspecific clinical symptoms[4]. Ultrasonography (US)-based diagnosis of small pancre-
atic tumors was based on the identification of a poorly
reflecting and attenuating pancreatic mass. The larger tu-
mors were more heterogeneous echogenically and exhibi-
ted well-defined irregular or lobulated margins [5]. US
usually reveals a well-circumscribed hypoechoic mass with
heterogeneous inner echoes. A CT scan may show a solid
tumor with heterogeneous density with or without a cystic
component. Some reports on the radiological aspects also
describe central areas of low attenuation on CT that pre-
sent cystic degeneration and necrosis of the tumor [6,7].
Our findings in the present case are consistent with some of
the above descriptions such as cystic degeneration of the
tumor.
The differential diagnosis of a cystic pancreatic lesion
includes pseudocyst, retention cyst, microcystic adenoma,
mucinous cystic neoplasm, papillary cystic tumor, cystic
islet tumor, nontumoral cyst in association with polycystic
disease, vascular tumors, cystic lymph node metastasis
(from primary cancer of the lung, ovary, or melanoma), and
primary hydatid disease of the pancreas [3]. The pancreas
is a rare location for a sarcoma and tumors arising from
other sites, such as retroperitoneum, female genital tract,
and soft tissues, may involve the pancreas, simulating a
primary pancreatic lesion [2]. In the present case, both
imaging studies and intraoperative impression ruled out an
extrapancreatic origin. Some suggest markedly shaggy and
thickened wall without definite cysts on CT should exclude
a pancreatic pseudocyst and other cystic tumors [3].
A correct preoperative diagnosis of cystic masses, arising
from the pancreatic or peri-pancreatic region, is important
for appropriate treatment. Imaging modalities including CT,
magnetic resonance imaging, and endoscopic US have
proven to be useful in assessing resectability. Surgical
resection is the only possible cure for pancreatic malig-
nancies. With respect to a pancreatic sarcoma, a definite
therapy recommendation is hard to make. Nonetheless,
radical resection seems to offer the best possibility for cure
[2]. Therefore, we performed aggressive surgical inter-
vention after explanation to the families. Fortunately, the
postoperative recovery was uneventful.
Pancreatic cancers usually have a poor prognosis
because they tend to be diagnosed in an advanced stage.
Pancreatic sarcomas tend to grow much more rapidly and
are believed to be associated with an even worse prognosis
[1]. Prognosis is influenced by patient age, tumor size,
presence of tumoral necrosis, and vascular invasion [2]. In
the present case, the prognosis seems not bad. This may be
due to the following reasons: resectability of the tumors,
less tumor necrosis, and no vascular invasion. In addition,
the patient was not old.
Special attention should be directed to the predominant
solid component of the mass to avoid misdiagnosing these
lesions as pseudocysts. In addition, the presence of a
pseudocyst does not exclude the possibility of a coexisting
malignant tumor of the pancreas. Some suggest positron
emission tomography scans may be useful in tumors with
liquefying necrosis that mimic pseudocysts or abscesses on
a CT scan [4].
In conclusion, pancreatic sarcomas are extremely rare.
They appear to be more aggressive and are associated with
a worse prognosis [1]. We should consider a pancreatic
Pancreatic Sarcoma Mimicking Pseudocyst 145tumor including sarcoma in the differential diagnosis of a
pancreatic cystic lesion in a patient with pancreatitis.
Awareness of the possibility may permit earlier diagnosis,
improve the management, and enhance the chance for
cure.
References
[1] Ambe P, Kautz C, Shadouh S, et al. K. Primary sarcoma of the
pancreas, a rare histopathological entity. A care report with
review of literature. World J Surg Oncol 2011;9:85e9.
[2] Zhang H, Jensen MH, Farnell MB, et al. Z. Primary leiomyo-
sarcoma of the pancreas: study of 9 cases and review of
literature. Am J Surg Pathol 2010;34:1849e56.[3] Laverdiere JT, vanSonnenberg E, Strum WB, et al. Pleomor-
phic pancreatic sarcoma mimicking pancreatic pseudocyst: CT
appearance. AJR 1992;158:87e9.
[4] Adamek HE, Albert J, Breer H, et al. Pancreatic cancer
detection with magnetic resonance cholangiopancreatog-
raphy and endoscopic retrograde cholangiopancreatography:
a prospective controlled study. Lancet 2000;356:190e3.
[5] Karlson BM, Ekbom A, Lindgren PG, et al. Abdominal US for
diagnosis of pancreatic tumor: prospective cohort analysis.
Radiology 1999;213:107e11.
[6] Machado MC, Cunha JE, Penteado S, et al. HS. Preoperative
diagnosis of pancreatic leiomyosarcoma. Int J Pancreatol
2000;28:97e100.
[7] Sperti C, Pasquali C, Prima F, et al. Duodenal leiomyosarcoma
mimicking a pancreatic pseudocyst. HPB Surg 1994;8:49e52.
